openPR Logo
Press release

HbA1c Testing Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

04-26-2018 03:52 PM CET | Health & Medicine

Press release from: CMI Research Report

HbA1c test is used to screen and diagnose for diabetes and prediabetes in patients. Hemoglobin molecule from the blood cell sticks to the glucose that gives rise to glycosylated hemoglobin molecule termed as hemoglobin A1C (HbA1C). Patients with high glucose level have more HbA1C present in blood. Average blood glucose level of a person can be diagnosed by measuring this glycosylated hemoglobin molecule. It is important for diabetic patient to know the glucose level, as there might be risk of diabetes related complications. HbA1c test is considered more effective than checking the blood glucose level. Blood glucose level gives the presence of glucose at a single point time whereas, the HbA1c test gives blood glucose level status for 2-3 months.

Browse the complete report and table of contents @ https://www.coherentmarketinsights.com/ongoing-insight/toc/945

Increase in healthcare expenditure over diabetes management is owing to the growth of HbA1c testing devices market

Growing diabetes patient population globally is one of the important factor driving the growth HbA1c testing devices market. According to World Health Organization (WHO), the number of patients with diabetes has increased from 108 million in 1980 to 422 million in 2014. Around 5 million deaths were reported in 2015 due to diabetes and 2.2 million deaths were attributed to high blood glucose level. The data given by International Diabetes Federation showed the expenditure of 673 billion USD on diabetes in 2015. Additionally, rise prescription by physicians for HbA1c test is contributing to the growth of HbA1c testing devices market. Moreover, factors such as growing awareness about diabetes preventive care, rise in geriatric and obese population which are more prone to diabetes, upgrading technologies for management of diabetes are expected to fuel the growth of HbA1c testing devices market. However, some factors are likely to hamper the growth of HbA1c testing devices market, such as high cost of testing devices and limitations for the results of certain population, which include pregnant women, elder people, and non-Hispanic black. HbA1c testing devices market have opportunities in future, due to untapped market and rise in demand for medical tourism.

Wide use of bench top devices in diagnostic laboratories owing to domination of device segment

The global HbA1c testing devices market is segmented by device- type, by technology, by end users, and by region

On the basis of device- type, the HbA1c testing devices market is segmented into

Bench top device,Handled device,.

On the basis of technology, the HbA1c testing devices market is segmented into

Assay,Enzymatic Assay,Turbidimetric inhibition immunoassay,Chromatography,Ion exchange HPLC,Affinity binding chromatography,Others,.

On the basis of end users, the HbA1c testing devices market is segmented into

Hospitals,Diagnostic laboratory,Research institutions,Homecare,.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/945

Rising diabetic population is attributed to the growth of HbA1c testing devices market in Asia Pacific

Regional segmentation of HbA1c testing devices market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The increase in number of patient population in North America is fuelling the growth of HbA1c testing devices market. Furthermore, the factors like established healthcare infrastructure and adoption to the technologically advanced medical devices, are helping North America to dominate in the HbA1c testing devices market. According to recent data given by International Diabetes Federation, there are around 109 million people in China and 69 million people in India with diabetes. The large number of diabetic population, unmet health needs, and development in healthcare sector are fuelling the growth of HbA1c testing devices market in Asia Pacific.

Product development is helping the organizations in HbA1c testing devices market to hold the top position

Key industry players operating the global HbA1c market includes Abbott Laboratories, Transasia Biomedicals limited, Alere Incorporated, Arkray Incorporated, Danaher Co., Bio-Rad Laboratories, Siemens Healthcare, F.Hoffmann-La Roche Limited, and Trinity Biotech Plc. The industry players are likely to get involved in product development for higher accuracy, reliable results, and quicker turnaround time for the analyzers. The factors like product development and approval of devices for diagnosis of diabetes are helping the organizations to hold the maximum share in the HbA1c testing devices market.

Browse Full Report at: https://www.coherentmarketinsights.com/ongoing-insight/hba1c-testing-devices-market-945

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HbA1c Testing Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025 here

News-ID: 1032258 • Views:

More Releases from CMI Research Report

Hospital Beds Market worth US$ 5.2 Billion by 2025 Globally
Hospital Beds Market worth US$ 5.2 Billion by 2025 Globally
Many of the hospitals have shifted their capital funds towards the hospital infrastructure, which is mainly seen in private hospitals. Improving healthcare amenities along with increasing spending in healthcare is expected to boost growth of hospitals beds market globally. Increasing number of geriatric population and need for their treatment is expected to fuel the growth of hospital bed market over the forecast period. The number of hospital beds are very
Acute Bacterial Skin and Skin Structure Infections Market Sales, Size, Leading Player & Forecast to 2025
Acute Bacterial Skin and Skin Structure Infections Market Sales, Size, Leading P …
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are the type of skin and soft tissue infections that affects the epidermis, dermis, and subcutaneous tissues. The US FDA defines ABSSSI as lesions with cellulitis/erysipelas, wound infections, and major cutaneous abscesses occurring in a minimum surface area of 75 cm2. Pathogens such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, and Pseudomonas
Adrenocortical Carcinoma Treatment Market 2017 Industry Analysis, Segment & Forecast up to 2025
Adrenocortical Carcinoma Treatment Market 2017 Industry Analysis, Segment & Fore …
Adrenocortical carcinoma is a rare cancer affecting the outer layer of the adrenal glands, which are responsible for producing certain hormones and maintaining optimum blood pressure levels. Adrenocortical carcinoma is relatively frequent in children compared to other cancers, although the cancer may also affect adults. The most common symptoms of adrenocortical carcinoma include abdominal pain, hypertension, weight gain, and frequent urination, which are mainly caused due to tumors causing excess
Primary Biliary Cirrhosis Drugs Market Overview, Trends and Growth Opportunities Forecasted till 2025
Primary Biliary Cirrhosis Drugs Market Overview, Trends and Growth Opportunities …
Primary biliary cirrhosis, known as primary biliary cholangitis is a chronic liver disease, which causes liver inflammation, fibrosis, and obstruction in the bile duct leading to destruction of small bile ducts within liver. Cause for primary biliary cirrhosis can be autoimmunity, infection and/or genetic predisposition. Symptoms of primary biliary cirrhosis includes itching, osteoporosis, elevated serum cholesterol, and malabsorption of fat and fat soluble vitamins, which can advance to hepatomegaly, hyperpigmentation,

All 5 Releases


More Releases for HbA1c

Increasing Diabetes Prevalence To Boost HbA1c Testing Demand: Transformative For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Hemoglobin A1c (HbA1c) Testing Industry Market Size Be by 2025? In recent times, there has been a swift expansion of the market size for Hemoglobin a1c (HbA1c) testing. The market, which was valued at $1.83 billion in 2024, is projected to rise to $2.03 billion in
Increasing Diabetes Prevalence To Boost HbA1c Testing Demand: An Emerging Driver …
The Hemoglobin A1c (HbA1c) Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Hemoglobin A1c (HbA1c) Testing Market? The hemoglobin A1c (HbA1c) testing market has grown rapidly in recent years. It will grow from $1.83 billion in 2024 to
Technological Innovations in HbA1c Home Testing Trend: A Crucial Influence on th …
"What industry-specific factors are fueling the growth of the hemoglobin a1c (hba1c) testing market? The increasing prevalence of diabetes is expected to propel the growth of the hemoglobin A1c (HbA1c) testing market. The rising cases of diabetes, fueled by poor diets and sedentary lifestyles, are driving the demand for HbA1c tests. These tests monitor long-term blood glucose control in diabetic individuals. According to The Lancet in June 2023, global diabetes cases
Transforming the Hemoglobin A1c (HbA1c) Testing Market in 2025: Increasing Diabe …
"What Is the Expected Size and Growth Rate of the Hemoglobin A1c (HbA1c) Testing Market? In recent years, there has been a substantial expansion in the market size for hemoglobin a1c (HbA1c) testing. The market, which was valued at $1.83 billion in 2024, is expected to increase to $2.03 billion in 2025, representing a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the historical period include
HbA1c Testing Market Insights, Forecast to 2031
"HbA1c Testing Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the HbA1c Testing market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the HbA1c Testing industry, providing stakeholders with a nuanced perspective on
HbA1c Testing Device Market Size 2024 to 2031.
Market Overview and Report Coverage HbA1c Testing Device Market is a medical device market that focuses on testing and monitoring the level of glycated hemoglobin in the blood, which is essential for managing diabetes. This market is driven by the increasing prevalence of diabetes worldwide, the rise in healthcare expenditure, and the growing awareness about the importance of regular HbA1c monitoring for diabetic patients. The future outlook of the HbA1c